Strontium chloride hexahydrate
Phase 3Small molecule
Strontium chloride hexahydrate is one of 56 small molecule programs targeting Amputation. It is currently in Phase 3.
2
Indications
2
Total Trials
0
Active Trials
55
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
778 competitors in Osteoarthritis
#DrugCompanyPhaseTrials
1Strontium chloride hexahydrate
SSantoSolve AS
Phase 3
Epidiolex
Jazz PharmaceuticalsPreclinical
Toradol
RochePreclinical
Bayer Aspirin
BayerPreclinical
Glucophage
Boehringer IngelheimPreclinical
MS Contin
HHikma Pharmaceuticals LLC
Preclinical
Chirocaine
PPurdue Pharma LP
Preclinical
Lunesta
Akero TherapeuticsPreclinical
Protonix
WWyeth-Lederle Vaccines
Preclinical
Precedex
MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Phase 3[1]
- Company
- SSantoSolve AS